Gene · 7480
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppressive Potential of Rosmarinus officinalis L. Extract against Triple-Negative and Luminal A Breast Cancer. | Int J Mol Cell Med | 2024 | 39184822 | PubTator, text mining | PubMed |
| Understanding pathophysiology and injury mechanisms is the foundation for invention/innovation and clinical translation in orthopaedics. | J Orthop Translat | 2024 | 39161656 | PubTator, text mining | PubMed |
| Irisin promotes hair growth and hair cycle transition by activating the GSK-3β/β-catenin pathway. | Exp Dermatol | 2024 | 39133009 | PubTator, text mining | PubMed |
| Exploring the relationship between anal fistula and colorectal cancer based on Mendelian randomization and bioinformatics. | J Cell Mol Med | 2024 | 39120548 | PubTator, text mining | PubMed |
| Systematic Druggable Genome-Wide Mendelian Randomization Identifies Therapeutic Targets for Functional Outcome After Ischemic Stroke. | J Am Heart Assoc | 2024 | 39119979 | PubTator, text mining | PubMed |
| Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system. | Bone Res | 2024 | 39103328 | PubTator, text mining | PubMed |
| Targeting WNT5B and WNT10B in osteosarcoma. | Oncotarget | 2024 | 39102216 | PubTator, text mining | PubMed |
| Wnt/β-catenin signaling pathway as an important mediator in muscle and bone crosstalk: A systematic review. | J Orthop Translat | 2024 | 39007034 | PubTator, text mining | PubMed |
| Design principles and therapeutic applications of novel synthetic WNT signaling agonists. | iScience | 2024 | 38832011 | PubTator, text mining | PubMed |
| El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo. | Adv Lab Med | 2024 | 38634083 | PubTator, text mining | PubMed |
| Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength. | Elife | 2024 | 38598270 | PubTator, text mining | PubMed |
| Fructooligosaccharides act on the gut-bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL/6 female mice. | JBMR Plus | 2024 | 38562914 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals Intrinsic Abnormalities in Endometrial Polyps. | Int J Mol Sci | 2024 | 38473810 | PubTator, text mining | PubMed |
| Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence. | Cell Death Dis | 2024 | 38388496 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| Compound heterozygous WNT10A missense variations exacerbated the tooth agenesis caused by hypohidrotic ectodermal dysplasia. | BMC Oral Health | 2024 | 38280992 | PubTator, text mining | PubMed |
| Gollop-Wolfgang Complex Is Associated with a Monoallelic Variation in WNT11. | Genes (Basel) | 2024 | 38275609 | PubTator, text mining | PubMed |
| Novel frameshift variant of WNT10A in a Japanese patient with hypodontia. | Hum Genome Var | 2024 | 38263268 | PubTator, text mining | PubMed |
| Liuwei Dihuang Pills Enhance Osteogenic Differentiation in MC3T3-E1 Cells through the Activation of the Wnt/β-Catenin Signaling Pathway. | Pharmaceuticals (Basel) | 2024 | 38256932 | PubTator, text mining | PubMed |
| Paraspinal muscles in individuals undergoing surgery for lumbar spine pathology lack a myogenic response to an acute bout of resistance exercise. | JOR Spine | 2024 | 38222805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7480/papers?page=5